Iovance Biotherapeutics, Inc.
IOVA
$6.98
$0.467.06%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -5.03% | 5.54% | -1.27% | -0.13% | -16.27% |
| Total Receivables | 24.90% | -0.84% | 23.50% | 11.38% | -15.51% |
| Inventory | -4.77% | 12.96% | -0.06% | 3.77% | -23.97% |
| Prepaid Expenses | -31.34% | 11.59% | 17.99% | -14.97% | -27.36% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -0.48% | 5.38% | 3.17% | 1.56% | -17.58% |
|
|
|||||
| Total Current Assets | -0.48% | 5.38% | 3.17% | 1.56% | -17.58% |
| Net Property, Plant & Equipment | -0.47% | -0.70% | 0.91% | 1.73% | 6.11% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -1.94% | -3.66% | -2.06% | -3.73% | 3.82% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -12.93% | 0.97% | -7.15% | -6.31% | 160.28% |
| Total Assets | -1.09% | 1.37% | 0.91% | -0.27% | -6.13% |
|
|
|||||
| Total Accounts Payable | -30.01% | 69.01% | -29.06% | -2.40% | 12.34% |
| Total Accrued Expenses | -10.64% | -20.25% | 26.30% | 6.22% | 0.73% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -31.44% | -22.68% | -30.74% | -9.78% | -15.04% |
| Total Finance Division Other Current Liabilities | -26.76% | -29.11% | 47.80% | -60.46% | 52.83% |
| Total Other Current Liabilities | -26.76% | -29.11% | 47.80% | -60.46% | 52.83% |
| Total Current Liabilities | -17.44% | -6.46% | 10.00% | -2.61% | 5.27% |
|
|
|||||
| Total Current Liabilities | -17.44% | -6.46% | 10.00% | -2.61% | 5.27% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -1.25% | -1.18% | -1.79% | 0.26% | 1.98% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -4.27% | -3.81% | 0.51% | -8.74% | 8.56% |
| Total Liabilities | -11.98% | -4.98% | 5.88% | -3.01% | 5.07% |
|
|
|||||
| Common Stock & APIC | 1.72% | 3.07% | 2.00% | 3.03% | 0.85% |
| Retained Earnings | -1.66% | -2.85% | -2.66% | -3.49% | -4.47% |
| Treasury Stock & Other | 3.38% | -23.05% | 2.09% | -22.80% | 231.41% |
| Total Common Equity | 1.98% | 3.32% | -0.53% | 0.54% | -9.04% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | 1.98% | 3.32% | -0.53% | 0.54% | -9.04% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.98% | 3.32% | -0.53% | 0.54% | -9.04% |
|
|
|||||